A novel and general spatiotemporal diagnostic model: Intratumoral outflow and peritumoral inflow for the differentiation and stratification of breast tumor.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
159 patients (80 malignant and 79 benign lesions) undergoing dynamic contrast-enhanced MRI was conducted.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] IOPI serves as a valuable tool that highlights the additional potential of spatiotemporal kinetic information for improving breast tumor diagnosis. The combined model which integrates time and spatial concepts, exhibited strong diagnostic performance for improved breast cancer diagnosis and risk stratification.
[OBJECTIVE] A novel Intratumoral Outflow and Peritumoral Inflow (IOPI) model based on spatiotemporal information was developed to quantify differences in blood perfusion and microcirculation.
- p-value p < 0.05
- Sensitivity 82.0 %
- Specificity 95.1 %
APA
Meng Z, Zhou C, et al. (2026). A novel and general spatiotemporal diagnostic model: Intratumoral outflow and peritumoral inflow for the differentiation and stratification of breast tumor.. European journal of radiology, 196, 112622. https://doi.org/10.1016/j.ejrad.2025.112622
MLA
Meng Z, et al.. "A novel and general spatiotemporal diagnostic model: Intratumoral outflow and peritumoral inflow for the differentiation and stratification of breast tumor.." European journal of radiology, vol. 196, 2026, pp. 112622.
PMID
41616757 ↗
Abstract 한글 요약
[OBJECTIVE] A novel Intratumoral Outflow and Peritumoral Inflow (IOPI) model based on spatiotemporal information was developed to quantify differences in blood perfusion and microcirculation. Its performance was compared with conventional indicators, and its clinical application for diagnosing benign and malignant breast tumors, as well as its potential for risk stratification, was validated in a two-center study.
[MATERIALS AND METHODS] A retrospective analysis of 159 patients (80 malignant and 79 benign lesions) undergoing dynamic contrast-enhanced MRI was conducted. Training set was from Center 1, testing set was from Center 2. Conventional kinetic parameters (PE and SER) and interpreted MRI features (ADC and BI-RADS) were extracted. Hemodynamics models (IOPI, IIO, PIO and IPIO) and combined models (ADC + IOPI, BIRADS + IOPI) were constructed by logistic regression. Classification performance was assessed by AUC, sensitivity, specificity and accuracy.
[RESULTS] In the training cohort, the proposed IOPI model achieved an AUC of 0.911, with specificity of 95.1 %, sensitivity of 82.0 % and accuracy of 89.5 %. In external testing cohort, the AUC was 0.802, significantly outperformed conven tional indicators and others models (p < 0.05). The BIRADS combined IOPI model achieved the highest diagnostic performance in classifying malignancy of breast lesions, with the AUC values of 0.940 and sensitivity of 92.0 % in training cohort. In the testing cohort, the ADC combined IOPI model achieved the highest diagnostic performance with the AUC of 0.878, accuracy of 84.2 % and specificity of 88.9 %. The combined models also showed comparable performance in stratifying invasive grades and predicting Ki-67 expression (exceptional specificity of 90.9 % in ADC combined IOPI).
[CONCLUSION] IOPI serves as a valuable tool that highlights the additional potential of spatiotemporal kinetic information for improving breast tumor diagnosis. The combined model which integrates time and spatial concepts, exhibited strong diagnostic performance for improved breast cancer diagnosis and risk stratification.
[MATERIALS AND METHODS] A retrospective analysis of 159 patients (80 malignant and 79 benign lesions) undergoing dynamic contrast-enhanced MRI was conducted. Training set was from Center 1, testing set was from Center 2. Conventional kinetic parameters (PE and SER) and interpreted MRI features (ADC and BI-RADS) were extracted. Hemodynamics models (IOPI, IIO, PIO and IPIO) and combined models (ADC + IOPI, BIRADS + IOPI) were constructed by logistic regression. Classification performance was assessed by AUC, sensitivity, specificity and accuracy.
[RESULTS] In the training cohort, the proposed IOPI model achieved an AUC of 0.911, with specificity of 95.1 %, sensitivity of 82.0 % and accuracy of 89.5 %. In external testing cohort, the AUC was 0.802, significantly outperformed conven tional indicators and others models (p < 0.05). The BIRADS combined IOPI model achieved the highest diagnostic performance in classifying malignancy of breast lesions, with the AUC values of 0.940 and sensitivity of 92.0 % in training cohort. In the testing cohort, the ADC combined IOPI model achieved the highest diagnostic performance with the AUC of 0.878, accuracy of 84.2 % and specificity of 88.9 %. The combined models also showed comparable performance in stratifying invasive grades and predicting Ki-67 expression (exceptional specificity of 90.9 % in ADC combined IOPI).
[CONCLUSION] IOPI serves as a valuable tool that highlights the additional potential of spatiotemporal kinetic information for improving breast tumor diagnosis. The combined model which integrates time and spatial concepts, exhibited strong diagnostic performance for improved breast cancer diagnosis and risk stratification.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Female
- Breast Neoplasms
- Middle Aged
- Sensitivity and Specificity
- Retrospective Studies
- Reproducibility of Results
- Diagnosis
- Differential
- Magnetic Resonance Imaging
- Aged
- Adult
- Image Interpretation
- Computer-Assisted
- Contrast Media
- Spatio-Temporal Analysis
- Breast cancer
- Ki-67
- Kinetic parameters
- Magnetic resonance imaging
- Non-invasive model
같은 제1저자의 인용 많은 논문 (5)
- inhibits neovascularization in colorectal cancer and its mechanism.
- Myeloid TGF-β signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis.
- Recombinant Detoxified Holotoxin as a Potent Candidate Vaccine Against Botulism.
- An infected iatrogenic through-and-through conchal defect after rhinoplasty.
- Insights on Chinese and European consensus for USgHIFU treatment of pancreatic cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.